New research has connected toxins produced by E. coli bacteria to the types of colorectal cancer tumors more likely to affect ...

Can ctDNA-guided therapy stop cancer’s return, sparing patients unnecessary treatment? A new study suggests it might.

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

Eleven high school students turned themselves into authorities after being involved in an alleged hazing incident, and a woman with Stage 4 colorectal cancer is cancer-free after new treatment.

Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease ...

Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...

The numbers for bowel cancer, the third-most-common type worldwide, are rising particularly fast. Compared with Americans ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

Colorectal cancer is a disease that affects the colon (large intestine) or rectum, which are parts of the digestive system.

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

Colorectal cancer has increased significantly over the past 20 years among adults under 50. Now scientists may have ...